Bone marrow aspiration technique may have an impact on therapy stratification in children with acute lymphoblastic leukaemia

2011 ◽  
Vol 57 (2) ◽  
pp. 224-226 ◽  
Author(s):  
Jon Helgestad ◽  
Steen Rosthøj ◽  
Preben Johansen ◽  
Kim Varming ◽  
Erik Østergaard
2020 ◽  
Vol 2020 ◽  
pp. 1-3
Author(s):  
I. Ranathunga ◽  
N. R. Muthumala ◽  
H. W. C. K. Kulathilake ◽  
S. Weerasinghe ◽  
N. L. A. Shyamali

Background. Bone marrow necrosis (BMN) is a rare entity which presents with bone pain, fever, and peripheral cytopenia. Acute lymphoblastic leukaemia (ALL) is characterized by malignant proliferation of immature lymphocytes, and patients usually present with fatigue and bleeding manifestations. Presentation with BMN is an extremely rare finding and only few cases had been reported in the literature. Case Presentation. A 22-year-old male presented with nocturnal lower back ache, pleuritic central chest pain, and fever for two weeks. He was extensively investigated for a cause. His investigations revealed pancytopenia with severe neutropenia. Initial bone marrow aspiration and biopsy did not provide a positive result due to extensive necrosis. However, immunohistochemical analysis of few immature lymphoid cells on repeated BM biopsy showed evidence of acute lymphoblastic leukaemia. Conclusions. ALL usually presents with fatigue and bleeding manifestations. Presentation with BMN is extremely rare. The diagnosis was extremely challenging as this patient had only occasional atypical cells in the peripheral blood film and the repeat bone marrow (BM) biopsy showed extensive necrosis.


2021 ◽  
Vol 71 (2) ◽  
pp. 469-72
Author(s):  
Hafiz Muhammad Murtaza ◽  
Tariq Ghafoor ◽  
Muhammad Shaheen Iqbal

Objective: To find out the rate of remission of Pre-B Acute Lymphoblastic Leukaemia in children at the end of induction treatment with United Kingdom Acute Lymphoblastic Leukaemia (UKALL) 2011 chemotherapy protocol. Study Design: Prospective observational study. Place and Duration of Study: Paediatric Oncology Unit, Combined Military Hospital Rawalpindi, from Nov 2017 to Oct 2018. Methodology: Data of newly diagnosed patients of Pre-B Acute lymphoblastic Leukaemia, between 1 and 15 years of age was analysed. Patients were divided into low and high-risk groups and treated with United Kingdom Acute Lymphoblastic Leukaemia 2011 induction chemotherapy on regimens A and B respectively. Bone marrow aspiration was performed at the end of induction therapy (28 days), to document their remission status. Patients having ≤5% of blast cells were categorized to be in remission state and those with >5% blast cells were not considered in a state of remission. Results: A total of 79 patients, 45 (57%) male and 34 (43%) females were enrolled. The mean age was 5.79 ± 3.59 years. Fever (86.1%) and pallor (77.2%) were the most common presentations. Fifty-three (67.1%) patients were treated with regimen A and 26 (32.9%) had regimen B chemotherapy. Febrile neutropenia and myopathy were the most common complications seen in 73 (92.4%) and 54 (71.1%) patients respectively. Eight patients (10.1%) died during induction chemotherapy. Bone marrow aspiration done at the end showed a 100% rate of remission for both regimens A and B. Conclusion: Risk-based treatment of paediatric Acute lymphoblastic Leukaemia............


The Lancet ◽  
1987 ◽  
Vol 329 (8536) ◽  
pp. 786-789 ◽  
Author(s):  
RogerH. Herzig ◽  
A. John Barrett ◽  
Eliane Gluckman ◽  
StevenJ. Jacobsen ◽  
Tohru Masaoka ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document